FDA Approves Vyalev (foscarbidopa and foslevodopa) for Adults Living with Advanced Parkinson's Disease NORTH CHICAGO, Ill., Oct. 17, 2024 /PRNewswire/ -- AbbVie (NYSE: ABBV) today announced that the U.S. Food and Drug Administration (FDA) has approved Vyalev (foscarbidopa and fos...
Press Releases Pharmaceutical CDMO Market Size to Surpass USD 368.70 Bn By 2034 December 17, 2024 · 13 min read Press Releases Viral Vector Production (Research-use) Market Size to Hit USD 7.62 Bn by 2034 December 17, 2024 · 1 min read ...
Costa Rica had become an "enormous warehouse" of drugs and an operations center for exports to Europe, authorities said. Apr 1, 2023 Gold's Gym owner among 6 feared dead after plane crash off Costa Rica The bodies of one adult and one child have been found, but they have not yet...
The patient was treated with proton pump inhibitors and received treatment for his comorbidities. Esophagogastroduodenoscopy was performed to assess improvement. The patient’s symptoms gradually resolved.Conclusion: This case is one of the few to show an association between alcohol abuse and acute ...
and metabolic disorders. Recent studies have underscored the role of the gut microbiome in conditions such as Parkinson’s disease (PD), with evidence indicating that gut dysfunction and pathological features can precede motor symptoms by decades. The use of in vivo animal models has demonstrated th...
Parkinson's & Movement disorders Parkinson's drug changes the gut microbiome for the worse due to iron deficiency, study reveals A new study has revealed that the widely prescribed Parkinson's disease drug entacapone significantly disrupts the human gut microbiome by inducing iron deficiency. ...
Parkinson's disease is the world's fastest growing neurological condition. Currently there are no drugs or therapies that slow or stop the progression of the disease. Jul 23, 2024 0 21 Medications Q&A: How future medications could be personalized on a 3D printer ...